Try our Advanced Search for more refined results
February 08, 2018
In Re Synergy Pharmaceuticals Inc. Securities Litigation
Case Number:
1:18-cv-00873
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Davis Polk
- Faruqi & Faruqi
- Kessler Topaz
- Levi & Korsinsky
- McCune Wright
- Pomerantz LLP
- Robbins Geller
- WeissLaw LLP
- Wolf Haldenstein
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
December 07, 2018
Synergy Pharma Looks To Ditch Suit Over Side Effects, Loan
Synergy Pharmaceuticals Inc. asked a New York federal judge on Thursday to toss an investor suit accusing the company of driving up its stock price by misrepresenting the side effect profile of its flagship medication and the terms of a $300 million private equity loan, saying no misstatements were ever made.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login